Intracerebral cell transplantation therapy for murine GM1 gangliosidosis

Brain and Development

Volumn 31, Issue 10, 2009, Pages 717-724

  Sawada, Tomo ^a   Tanaka, Akemi ^a   Higaki, Katsumi ^b   Takamura, Ayumi ^b   Nanba, Eiji ^b   Seto, Toshiyuki ^a,d   Maeda, Mitsuyo ^a   Yamaguchi, Etsuko ^a   Matsuda, Junichiro ^c   Yamano, Tunekazu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d Fujiidera City Hospital   (Japan)

Author keywords

Cell transplantation; Fetal brain cell; GM1 gangliosidosis; Mesenchymal stem cell

Indexed keywords

GANGLIOSIDE GM1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FETUS; GM1 GANGLIOSIDOSIS; GRAFT RECIPIENT; GRAFT SURVIVAL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEWBORN; NONHUMAN; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TRANSPLANTATION TOLERANCE;

ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BRAIN TISSUE TRANSPLANTATION; CELLS, CULTURED; CEREBRAL CORTEX; FETAL TISSUE TRANSPLANTATION; GANGLIOSIDOSIS, GM1; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 70350155729     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2008.11.004     Document Type: Article

References (43)

1. Shen J.S., Watabe K., Ohashi T., and Eto Y. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Gene Ther 8 (2001) 1081-1087
2. Takaura N., Yagi T., Maeda M., Nanba E., Oshima A., Suzuki Y., et al. Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer. Gene Ther 10 (2003) 1487-1493
3. Kim E.Y., Hong Y.B., Lai Z., Cho Y.H., Brady R.O., and Jung S.C. Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector. J Gene Med 7 (2005) 878-887
4. Shen J.S., Meng X.L., Yokoo T., Sakurai K., Watabe K., Ohashi T., et al. Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease. J Gene Med 7 (2005) 540-551
5. Cachón-González M.B., Wang S.Z., Lynch A., Ziegler R., Cheng S.H., and Cox T.M. Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci USA 103 (2006) 10373-10378
6. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96 (1999) 10711-10716
7. Jin H.K., Carter J.E., Huntley G.W., and Schuchman E.H. Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 109 (2002) 1183-1191
8. Sakurai K., Iizuka S., Shen J.S., Meng X.L., Mori T., Umezawa A., et al. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice. Gene Ther 11 (2004) 1475-1481
9. Givogri M.I., Galbiati F., Fasano S., Amadio S., Perani L., Superchi D., et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci 26 (2006) 3109-3119
10. Kakkis E., McEntee M., Vogler C., Le S., Levy B., Belichenko P., et al. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I. Mol Genet Metab 83 (2004) 163-174
11. Dickson P., McEntee M., Vogler C., Le S., Levy B., Peinovich M., et al. Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid. Mol Genet Metab 91 (2007) 61-68
12. Vogler C., Levy B., Grubb J.H., Galvin N., Tan Y., Kakkis E., et al. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 102 (2005) 14777-14782
13. Matzner U., Herbst E., Hedayati K.K., Lüllmann-Rauch R., Wessig C., Schröder S., et al. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Hum Mol Genet 14 (2005) 1139-1152
14. Blanz J., Stroobants S., Lüllmann-Rauch R., Morelle W., Lüdemann M., D'Hooge R., et al. Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in {alpha}-mannosidosis mice. Hum Mol Genet 17 (2008) 3437-3445
15. Grubb J.H., Vogler C., Levy B., Galvin N., Tan Y., and Sly W.S. Chemically modified {beta}-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 105 (2008) 2616-2621
16. Montaño A.M., Oikawa H., Tomatsu S., Nishioka T., Vogler C., Gutierrez M.A., et al. Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice. Mol Genet Metab 94 (2008) 178-189
17. Kasperzyk J.L., El-Abbadi M.M., Hauser E.C., D'Azzo A., Platt F.M., and Seyfried T.N. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis. J Neurochem 89 (2004) 645-653
18. Lachmann R.H., te Vruchte D., Lloyd-Evans E., Reinkensmeier G., Sillence D.J., Fernandez-Guillen L., et al. Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis 16 (2004) 654-658
19. Cox T.M. Substrate reduction therapy for lysosomal storage diseases. Acta Paediatr Suppl. 94 (2005) 69-75
20. Piotrowska E., Jakóbkiewicz-Banecka J., Barańska S., Tylki-Szymańska A., Czartoryska B., Wegrzyn A., et al. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14 (2006) 846-852
21. Ishii S., Yoshioka H., Mannen K., Kulkarni A.B., and Fan J.Q. Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: a biochemical animal model for studying active-site specific chaperone therapy for Fabry disease. Biochim Biophys Acta 1690 (2004) 250-257
22. Matsuda J., Suzuki O., Oshima A., Yamamoto Y., Noguchi A., Takimoto K., et al. Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis. Proc Natl Acad Sci USA 100 (2003) 15912-15917
23. Matsuda J., Suzuki O., Oshima A., Ogura A., Noguchi Y., Yamamoto Y., et al. Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis. Glycoconj J 14 (1997) 729-736
24. Yamamoto Y., Nagase Y., Noguchi A., Mochida K., Nakahira M., Takano K., et al. Generation and characterization of the β-galactosidase knockout mouse having the normal human β-galactosidase gene as a transgene (in Japanese). Proc Jap Soc of Animal Models for Hum Dis (Nippon Shikkan Model Gakkai Kiroku) 17 (2001) 20-22
25. Meirelles Lda S., and Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123 (2003) 702-711
26. Meberg P.J., and Miller M.W. Culturing hippocampal and cortical neurons. Methods Cell Biol 71 (2003) 111-127
27. Suzuki K. Enzymatic diagnosis of sphingolipidosis. Methods Enzymol 138 (1987) 727-762
28. Bradford M.M. A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 255-260
29. Michikawa M., Gong J.S., Fan Q.W., Sawamura N., and Yanagisawa K. A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release. J Neurosci 21 (2001) 7226-7235
30. Suzuki Y., Ichinomiya S., Kurosawa M., Ohkubo M., Watanabe H., Iwasaki H., et al. Chemical chaperone therapy: clinical effect in murine G(M1)-gangliosidosis. Ann Neurol 62 (2007) 671-675
31. Barker R.A., and Widner H. Immune problems in central nervous system cell therapy. NeuroRx 1 (2004) 472-481
32. Abordo-Adesida E., Follenzi A., Barcia C., Sciascia S., Castro M.G., Naldini L., et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 16 (2005) 741-751
33. Lowenstein P.R., Kroeger K., and Castro M.G. Immunology of neurological gene therapy: how T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses. Neurotherapeutics 4 (2007) 715-724
34. Weimann J.M., Charlton C.A., Brazelton T.R., Hackman R.C., and Blau H.M. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 100 (2003) 2088-2093
35. Abouelfetouh A., Kondoh T., Ehara K., and Kohmura E. Morphological differentiation of bone marrow stromal cells into neuron-like cells after co-culture with hippocampal slice. Brain Res 1029 (2004) 114-119
36. Wislet-Gendebien S., Hans G., Leprince P., Rigo J.M., Moonen G., and Rogister B. Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype. Stem cells 23 (2005) 392-402
37. Deng J., Petersen B.E., Steindler D.A., Jorgensen M.L., and Laywell E.D. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. Stem cells 24 (2006) 105410-105464
38. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
39. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
40. Kozorovitskiy Y., and Gould E. Stem cell fusion in the brain. Nat Cell Biol 5 (2003) 952-954
41. Bae J.S., Furuya S., Shinoda Y., Endo S., Schuchman E.H., Hirabayashi Y., et al. Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice. Hum Gene Ther 16 (2005) 1006-1011
42. Tomatsu S., Gutierrez M., Nishioka T., Yamada M., Yamada M., Tosaka Y., et al. Development of MPS IVA mouse (Galnstm(hC79S. mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum Mol Genet 14 (2005) 3321-3325
43. Matzner U., Matthes F., Herbst E., Lüllmann-Rauch R., Callaerts-Vegh Z., D'Hooge R., et al. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy. Mol Med 13 (2007) 471-479